AMPH Stock Summary and Trading Ideas (Amphastar Pharmaceuticals | NASDAQ:AMPH)

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Amphastar Pharmaceuticals trades on the NASDAQ stock market under the symbol AMPH.

As of January 14, 2025, AMPH stock price climbed to $38.48 with 482,246 million shares trading.

AMPH has a beta of 0.65, meaning it tends to be less sensitive to market movements. AMPH has a correlation of 0.06 to the broad based SPY ETF.

AMPH has a market cap of $1.85 billion. This is considered a Small Cap stock.

Last quarter Amphastar Pharmaceuticals reported $191 million in Revenue and $.96 earnings per share. This fell short of revenue expectation by $-3 million and missed earnings estimates by -$.03.

In the last 3 years, AMPH traded as high as $67.66 and as low as $22.07.

The top ETF exchange traded funds that AMPH belongs to (by Net Assets): IJR, VTI, CALF, IWM, VXF.

AMPH has underperformed the market in the last year with a return of -29.0%, while the SPY ETF gained +23.6%. In the last 3 month period, AMPH fell short of the market, returning -19.1%, while SPY returned +0.8%. However, in the most recent 2 weeks AMPH has outperformed the stock market by returning +4.5%, while SPY returned -1.0%.

AMPH support price is $36.87 and resistance is $38.97 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AMPH shares will trade within this expected range on the day.